Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents

Figure 1

Plasma TF activity (a), antigen (b), and adipose TF mRNA levels (c) in obese T2D subjects compared with obese nondiabetics. For panels (a) and (b), N = 10–13 ± SD. For panel (c), N = 6–10 ± SD. nondiabetics versus T2D. Clinical characteristics of subjects are indicated in Table 1(a).

(a)

(b)

(c)